BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34009477)

  • 21. Clinical Outcomes of Patients with Small Rectal Neuroendocrine Tumors Treated Using Endoscopic Submucosal Resection with a Ligation Device.
    Takita M; Sakai E; Nakao T; Kimoto Y; Ishii R; Konishi T; Ueno S; Kanda K; Negishi R; Muramoto T; Hashimoto H; Morikawa T; Matsuhashi N; Ohata K
    Digestion; 2019; 99(1):72-78. PubMed ID: 30554202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can the Ki-67 Labeling Index in Biopsy Specimens Predict the World Health Organization Grade of Rectal Neuroendocrine Tumors?
    Sugimoto S; Hotta K; Shimoda T; Imai K; Ito S; Yamaguchi Y; Takizawa K; Kakushima N; Tanaka M; Kawata N; Yoshida M; Ishiwatari H; Matsubayashi H; Ono H
    Dig Dis; 2018; 36(2):118-122. PubMed ID: 29130971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of endoscopic submucosal dissection for gastrointestinal neuroendocrine tumors: a 10-year data analysis of Northern China.
    Chen X; Li B; Wang S; Yang B; Zhu L; Ma S; Wu J; He Q; Zhao J; Zheng Z; Li S; Wang T; Liang L
    Scand J Gastroenterol; 2019 Mar; 54(3):384-389. PubMed ID: 31037980
    [No Abstract]   [Full Text] [Related]  

  • 24. [Rectal neuroendocrine tumors: endoscopic therapy].
    Eick J; Steinberg J; Schwertner C; Ring W; Scherübl H
    Chirurg; 2016 Apr; 87(4):288-91. PubMed ID: 26801755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utility of endoscopic submucosal dissection using the pocket-creation method with a HookKnife and preoperative evaluation by endoscopic ultrasonography for the treatment of rectal neuroendocrine tumors.
    Hamada Y; Tanaka K; Hattori A; Umeda Y; Yukimoto H; Yamada R; Nakamura M; Miura H; Tsuboi J; Katsurahara M; Horiki N; Takei Y
    Surg Endosc; 2022 Jan; 36(1):375-384. PubMed ID: 33492506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of modified endoscopic mucosal resection for rectal neuroendocrine tumors: a meta-analysis.
    Zheng JC; Zheng K; Zhao S; Wang ZN; Xu HM; Jiang CG
    Z Gastroenterol; 2020 Feb; 58(2):137-145. PubMed ID: 32050284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is endoscopic ultrasonography essential for endoscopic resection of small rectal neuroendocrine tumors?
    Park SB; Kim DJ; Kim HW; Choi CW; Kang DH; Kim SJ; Nam HS
    World J Gastroenterol; 2017 Mar; 23(11):2037-2043. PubMed ID: 28373770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcomes according to additional treatments after endoscopic resection for rectal small neuroendocrine tumors.
    Cha JH; Jung DH; Kim JH; Youn YH; Park H; Park JJ; Um YJ; Park SJ; Cheon JH; Kim TI; Kim WH; Lee HJ
    Sci Rep; 2019 Mar; 9(1):4911. PubMed ID: 30894571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphovascular invasion in more than one-quarter of small rectal neuroendocrine tumors.
    Kwon MJ; Kang HS; Soh JS; Lim H; Kim JH; Park CK; Park HR; Nam ES
    World J Gastroenterol; 2016 Nov; 22(42):9400-9410. PubMed ID: 27895428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Endoscopic Treatment Outcome of Rectal Neuroendocrine Tumors Removed by Ligation-assisted Endoscopic Submucosal Resection].
    Gu MG; Lee SH
    Korean J Gastroenterol; 2018 Sep; 72(3):128-134. PubMed ID: 30270594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short- and Long-term Outcomes of Laparoscopic Total Mesenteric Excision for Neuroendocrine Tumors of the Rectum.
    Takatsu Y; Fukunaga Y; Nagasaki T; Akiyoshi T; Konishi T; Fujimoto Y; Nagayama S; Ueno M
    Dis Colon Rectum; 2017 Mar; 60(3):284-289. PubMed ID: 28177990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumors: Who Needs a Radical Resection in Rectal Neuroendocrine Tumors Sized 1-2 cm?
    Choi JS; Kim MJ; Shin R; Park JW; Heo SC; Jeong SY; Park KJ; Ryoo SB
    Ann Surg Oncol; 2024 Apr; 31(4):2414-2424. PubMed ID: 38194045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrence after endoscopic resection of small rectal neuroendocrine tumors: a retrospective cohort study.
    Pattarajierapan S; Khomvilai S
    Ann Coloproctol; 2022 Jun; 38(3):216-222. PubMed ID: 34280965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term prognosis of an endoscopically treated rectal neuroendocrine tumor: 10-year experience in a single institution.
    Sung HY; Kim SW; Kang WK; Kim SY; Jung CK; Cho YK; Park JM; Lee IS; Choi MG; Chung IS
    Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):978-83. PubMed ID: 22647741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of endoscopic submucosal dissection and transanal endoscopic microsurgery for T1 rectal neuroendocrine tumors: a propensity score-matched study.
    Park SS; Kim BC; Lee DE; Han KS; Kim B; Hong CW; Sohn DK
    Gastrointest Endosc; 2021 Aug; 94(2):408-415.e2. PubMed ID: 33600807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis on risk factors of positive vertical resection margin after endoscopic treatment of rectal neuroendocrine tumors].
    Wang RG; Jiang X; Ren YT; Wang J; Guo XJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jul; 22(7):643-647. PubMed ID: 31302962
    [No Abstract]   [Full Text] [Related]  

  • 37. T1 adenocarcinoma of the rectum: transanal excision or radical surgery?
    Bentrem DJ; Okabe S; Wong WD; Guillem JG; Weiser MR; Temple LK; Ben-Porat LS; Minsky BD; Cohen AM; Paty PB
    Ann Surg; 2005 Oct; 242(4):472-7; discussion 477-9. PubMed ID: 16192807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes of gastroduodenal neuroendocrine tumors according to their WHO grade: A single-institutional retrospective analysis.
    Ryu DG; Kim SJ; Choi CW; Kang DH; Kim HW; Park SB; Nam HS; Lee SH; Hwang SH
    Medicine (Baltimore); 2022 Sep; 101(37):e30397. PubMed ID: 36123854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors: Improving Its Prognostic Value for Recurrence of Disease.
    Lopez-Aguiar AG; Ethun CG; Postlewait LM; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Sarmiento JM; Kooby DA; Staley CA; Maithel SK; Cardona K
    Ann Surg Oncol; 2018 Jan; 25(1):290-298. PubMed ID: 29079920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastric Neuroendocrine Tumors According to the 2019 World Health Organization Grading System: A Single-Center, Retrospective Study.
    Kim Y; Ahn B; Choi KD; Kim BS; Yook JH; Lee GH; Hong SM; Lee JH
    Gut Liver; 2023 Nov; 17(6):863-873. PubMed ID: 36588525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.